---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-028615"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2026-06-15T12:01:16+00:00"
generated_at: "2026-06-15T12:06:48.125518+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech regains NYSE American listing compliance after equity deficiency resolved

## Summary
- Received NYSE American notice on June 12, 2026 that it resolved stockholders' equity deficiencies under Sections 1003(a)(i)-(iii).
- Raised ~$8.5M total through warrant exercises and stock sales: $3.5M (May 7 warrant inducement), $2.4M (May 21 placement), $2.6M (June 10 placement).
- Issued over 10M shares and warrants; believes stockholders' equity now exceeds $6M minimum requirement.
- ".BC" indicator to be removed from trading symbol (AIM); company removed from NYSE American noncompliant list.

## SEC filing metadata
- accession: 0001493152-26-028615
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2026-06-15T12:01:16+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315226028615/0001493152-26-028615-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315226028615/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-028615
- JSON: https://secwatch.observer/filing/0001493152-26-028615.json
- Plain text: https://secwatch.observer/filing/0001493152-26-028615.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.